AstraZeneca
AZN
#51
Rank
A$413.68 B
Marketcap
A$266.74
Share price
-1.52%
Change (1 day)
-1.18%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): A$10.35

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is A$10.58. In 2024 the company made an earnings per share (EPS) of A$6.75 an increase over its 2023 EPS that were of A$5.71.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$10.35
2024A$6.7518.23%
2023A$5.7181.13%
2022A$3.15631.03%
2021A$0.43-88.11%
2020A$3.63136.89%
2019A$1.53-39.41%
2018A$2.53-28.27%
2017A$3.52-14.37%
2016A$4.1124.11%
2015A$3.31127.55%
2014A$1.46-51.96%
2013A$3.03-58.95%
2012A$7.39-32.2%
2011A$10.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.93-6.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.80-26.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.06-90.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$4.02-62.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$45.90 333.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.94-72.18%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$3.51-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.48-86.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.72-36.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.28-59.59%๐Ÿ‡ฌ๐Ÿ‡ง UK